(R)-or (S)-2-Hydroxy-4-(methylthio)butanoic acid (HMTBA) is used as a poultry nutritional supplement and to treat renal failure disease. Herein, we report an artificially designed biocatalytic cascade process, which uses l-methionine to synthesize (R)-or (S)-HMTBA. This biocatalysis cascade comprises a basic module and two different extender modules and operates in a modular assembly manner. The basic module responsible for the transformation of l-methionine to α-keto-γ-methylthiobutyric acid (KMTB) is comprised of the l-amino acid deaminase. Two different extender modules responsible for the transformation of KMTB to (R)-or (S)-HMTBA are comprised of the R/S-specific lactate dehydrogenase in combination with the formate dehydrogenase, respectively. Engineered Escherichia coli catalysts, one containing the basic module, the other containing the one of two different extender modules, produced 97.6 g L −1 (R)-HMTBA and 96.4 g L −1 (S)-HMTBA with a yield of 96.9% and 95.8% at the large scale (1 L) using a two-stage strategy in one pot, respectively. Therefore, this biocatalytic process lays the foundation for the industrialscale conversion of low-cost l-amino acids to corresponding high-value enantiopure chiral 2-hydroxy acids.
Introduction 2-Hydroxy acids, which bear a hydroxyl group at the alpha site related to a carboxylic group such as phenyllactic acid, 4-hydroxyphenyl lactic acid (Busto et al. 2014 ) and mandelic acid (Xue et al. 2016) , are commonly applied in feeds, antiseptic agents, and pharmaceuticals (Song et al. 2016; Yao et al. 2016) . One of the most commercially important 2-hydroxy acids is 2-hydroxy-4-(methylthio)butanoic acid (HMTBA) (Busto et al. 2014) , which is a pro-drug of compound α-keto acid tablets, as it is highly more stable and shows beneficial properties in treating renal failure disease (Masud et al. 1994) . In addition, as a methionine precursor, HMTBA is widely used as a poultry nutritional supplement since it is available in liquid form and has specific nutritional (Martin-Venegas et al. 2013; Tang et al. 2011 ) and anti-microbial properties (Dibner and Buttin 2002) . Thus, to meet the increasing market demand, a practical method for the preparation of HMTBA is required.
There are two main methods currently used to produce HMTBA: chemical and enzyme methods. There are several approaches for the chemical de novo synthesis of HMTBA, including hydrolysis (e.g., with cyanohydrin and ester) (Matsuoka 1993; Ruest et al. 1985; Tsuyoshi and Masahiro 2006) and oxidation (e.g., with butadiene and ketoalcohol) (Hagiya 2008; Koji and Hiroyuki 2009) . Currently, the cyanohydrin hydrolysis process (Tsuyoshi and Masahiro 2006) is the most notable commercial method for HMTBA production, using acrolein and methanethiol as the raw materials in the presence of an organic amine salt to form 3-methylthio propanal, which then reacts with hydrocyanic acid to produce 2-hydroxy-4-(methylthio)butanenitrile (HMTBN), followed by hydrolysis of sulfuric acid to HMTBA. However, there are several drawbacks associated with this process, such as the high energy requirement given the need for high temperature and pressure in the final step (hydrolysis of HMTBN by sulfuric acid to HMTBA), potential environmental hazards, and the use of toxic acrolein, methanethiol, and hydrocyanic acid as materials.
Alternatively, biocatalytic production processes offer several advantages such as a reaction operation under milder conditions (i.e., ambient temperature and pressure), and the use of fewer and less toxic chemicals (Luo and Lee 2017) . There are two reported biotransformation-based methods for producing HMTBA, involving a petroleum-derived raw substrate (HMTBN) or a biomass-derived substrate (l-methionine; l-Met). The first biocatalytic process developed for HMTBA involved nitrilase or nitrile hydratase. Nitrilase was used to directly hydrolyze HMTBN to HMTBA (Olivier et al. 2001; Jin et al. 2016) , whereas HMTBN was hydrated by nitrile hydratase to 2-hydroxy-4-(methylthio)butanamide (HMTBAm), followed by a chemical or amidase reaction to transform HMTBAm to HMTBA (D et al. 2000) . Despite the good yields obtained with this method, it requires HMTBN as an indispensable starting material that is spontaneously decomposed into 3-(methylthio)propionaldehyde and toxic hydrocyanic acid. Alternatively, HMTBA can be synthesized from lMet via two transformation steps: (i) l-Met to α-keto-γ-methylthiobutyric acid (KMTB), and (ii) KMTB to HMTBA. The first step involves the work of four enzymes: l-amino acid oxidase (l-AAO), l-amino acid deaminase (l-AAD), α-amino acid aminotransferase, and l-amino acid dehydrogenase (Molla et al. 2017; Xue et al. 2018) . Considering the irreversible nature of the reactions, l-AAO and l-AAD are prioritized. More recently, l-AAD from Proteus vulgaris was used for the bioconversion of l-Met to KMTB. The engineered strain Pvl-AAD K104R/A337S produced 63.6 g L −1 of KMTB in 24 h with a conversion rate of 91.4% (Hossain et al. 2014) ; however, there are no reports on the second step alone.
In addition, Busto et al. (2014) combined the two transformations steps using a multi-enzyme cascade with l-AAD from Proteus myxofaciens and d-or l-isocaproate reductases from Lactobacillus paracasei DSM 20008 or Lactobacillus confuses DSM 201966 coupled with formate dehydrogenase (FDH)-mediated NADH regeneration to produce (R)-or (S)-HMTBA, respectively. In simultaneous mode in one pot, 30 g L −1 (R)-or (S)-HMTBA was obtained at the milligram scale with a conversion rate of 99.0% from l-Met after 14 h.
However, this type of transformation at a larger scale suitable for industrial application has not yet been developed. Here, we report an artificially designed biocatalysis cascade protocol that could transform l-Met to KMTB, followed by transformation to (R)-or (S)-HMTBA. The platform was designed as a modular assembly, enabling the tunable and predictable operation of the biocatalysis cascade. The modular assembly involving the basic module and the extender module has been applied to transformation of simple achiral glycine and aldehydes to synthesize stereodefined α-functionalized organic acids (Song et al. 2018 ). This method was suitable for application as a high-yield, high-productivity platform for scaled-up HMTBA biosynthesis in a 1-L biocatalytic reaction system.
Methods
Strains, media, plasmids, reagents, and culture conditions Commercial reagents, standards, and solvents were purchased from Sigma-Aldrich, Meryer Chemicals, Aladdin, and TCI chemicals, and used without further purification. The expression plasmid pET-28a(+) and the host strain E. coli BL21 (DE3) were purchased from Novagen (Madison, WI, USA). The Bacillus coagulans and Pediococcus acidilactici were conserved in China General Microbiological Culture Collection Center (CGMCC), with preservation CGMCC No.: 1.2407 and No.: 1.2696, respectively. Cultivation for gene manipulation and plasmid construction was performed in Luria-Bertani broth or agar plates (2% agar, w/v). Cultivation for E. coli cell and enzyme expression for recombinant were performed in the Terrific Broth medium with 50 mg L −1 kanamycin.
Construction of the strains
All genetic constructions were carried out using standard molecular biology techniques with LATaq and rTaq DNA polymerase, restriction enzymes and T4 DNA ligase (all from Takara, Japan). Cloning inserts were created via PCR of ORFs of interest from their respective genomic or codon-optimized DNA with Phusion polymerase. Heterologous genes were amplified from their respective genomic DNA except for Pvl-AAD (GenBank Accession No. MK258171) and CbFDH (GenBank Accession No. MK258172), which were synthesized by GenScript (Piscataway, NJ) with codon optimization. Genes of R-specific lactate dehydrogenase (d-LDH) (KEGG: A4V11_01320) and S-specific lactate dehydrogenase (l-LDH) (KEGG: Bcoa_0653) were amplified from the genome of Pediococcus acidilactici and Bacillus coagulans, respectively. Main primers used for constructing co-expressed strains are summarized in Additional file 1: Table S1 . Candida boidinii FDH was first inserted into the pET28a(+) using the restriction sites BamHI and SalI, followed with an insertion of Pediococcus acidilactici d-LDH gene and Bacillus coagulans l-LDH gene using the SalI and XhoI site, respectively.
Analytical methods
l-Met levels were determined by HPLC using a FLD detector with an Agilent Zorbax SB-Aq column (4.6 × 150 mm). HPLC analysis of l-Met was performed by automatic precolumn derivatization with o-phthalaldehyde (OPA). Fluorescent derivatives were detected by excitation at 330 nm and emission at 465 nm. Samples (8 µL) were mixed with 4 µL of OPA derivatization reagent (30 mg OPA in 1 mL methanol, 53 µL ME and 9 mL 0.5 M potassium borate buffer, pH 9.2) and stored at − 20 °C for no more than 7 days before use. The polar eluent was 10 mM KH 2 PO 4 pH 5.3 (buffer A), and the nonpolar eluent was a 5:3:1 (v/v/v) mixture of acetonitrile, methanol and 10 mM KH 2 PO 4 (buffer B). The gradient was applied as follows: 0 min 80% A, 4 min 73% A, 8 min 50% A, 12 min 30% A, 16 min 25% A, 20 min 20% A, 24 min 40% A, 28 min 60% A, 32 min 80% A. A flow rate of 1 mL min −1 121 was maintained throughout. Quantitation of KMTB and HMTBA was performed by reverse-phase high-performance liquid chromatography (HPLC) using an Aminex ® HPX-87H ion (300 mm × 250 mm) exclusion column with UV detector at 210 nm. The mobile phase was a 5 mM H 2 SO 4 solution at a flow rate of 0.6 mL/min and a column temperature of 35 °C. The injection volume was 10 μL.
Analysis of the e.e. of HMTBA was conducted using Agilent 1260 HPLC with Daicel CHIRALPAK IG-3 column (250 × 4.6 mm, 3 µm; Daicel Co., Japan) with UV detector at 205 nm. The mobile phase was triethylamine (0.1%, pH 3.0)/methanol = 4:6 at a flow rate of 0.2 mL/ min and a column temperature of 25 °C. The injection volume was 4 μL. Samples were centrifuged and then the supernatants were filtered using 0.22-μm filter membrane.
Enzyme assay
l-AAD/l-AAO activity on l-Met was assayed by coupling KMTB formation. One unit of activity was defined as the amount of catalyst that catalyzed the oxidation of 1 μmol l-Met per minute under the following conditions: 25 °C, pH 7.5. The assay mixture contained the substrate solution (10 mM) and the E. coli cells containing overexpressed l-AAD (5 mg). The conversion was determined between 1 and 2.5 min each 30 s. Dehydrogenase activity on KMTB was determined as described previously (Busto et al. 2014) . One unit of activity was defined as the amount of catalyst that catalyzes the oxidation of 1 μmol NADH per minute by measurement of the absorbance at 340 nm.
Strategy in fed-batch fermentation
Seed cultures were grown in 500 mL of LB medium and then inoculated in the 5-L bioreactor fermentation with a 3-L working volume, with an inoculation with 5% volume of the seed culture. The pH, agitation rate, and aeration rate were adjusted to 7.0, 400 rpm, and 1.0 vvm, respectively. The temperature for cell growth was 37 °C, but after induced with 5 g L −1 lactose, the temperature was adjusted to 25 °C for enzyme expression. When the dissolved oxygen level increased rapidly (demonstrating glycerol in the medium was completely exhausted), the system was supplied with 400 g L −1 glucose, 100 g L −1
yeast extract, and 25 g L −1 tryptone at a rate of 8 mL h −1 .
Production of R/S-HMTBA from l-Met
The conversion experiments were carried out a 5-L bioreactor with 1-L working volume. Pvl-AAD (20 g L −1 wet biomass) was added to a Tris-HCl buffer (20 mM, pH 7.5) containing the l-methionine (100 g L
−1
). The suspension was stirred at 600 rpm, 25 °C and aeration rate of 2 vvm for 14 h. After this time, the R-selective wholecell catalyst (20 g L −1 wet biomass) or the S-selective whole-cell catalyst (20 g L −1 wet biomass) and 140 g L −1
formate, and 0.4 mM NAD + were added at 30 °C. After a further 9-h incubation, the concentration of KMTB, l-Met, and HMTBA was determined using the HPLC method as described above.
Isolation protocols
The isolation protocol was the same as the previous report (Busto et al. 2014) .
Results

Designing enzyme cascades for producing (R/S)-HMTBA
The catalysis cascade platform was designed with two main modules (Fig. 1a) . The first module is the basic module (BM), in which l-Met is transformed to prochiral KMTB. The other module is the extender module (EM) that is split into two parts, EM1 and EM2, in which KMTB is converted into (R)-and (S)-HMTBA, respectively. When BM is coupled with EM1, the complete process is found to produce (R)-HMTBA (Fig. 1b) . Similarly, when BM is coupled with EM2, the complete process is found to produce (S)-HMTBA. Thus, we could obtain KMTB, (R)-HMTBA, and (S)-HMTBA simply with the readily available material l-Met (Fig. 1) .
The BM starts with the oxidation of l-Met using l-AAO or l-AAD to produce KMTB (Fig. 1a) . Both l-AAO and l-AAD employ FAD to catalyze the typical deamination of l-Met, yielding the corresponding KMTB and ammonia. The EMs were designed for introducing chiral -OH groups (Fig. 1a) . EM1 was designed for the R-stereoselective reduction of KMTB to (R)-HMTBA catalyzed by R-specific dehydrogenases, coupled with NADH recycling by FDH, while EM2 was designed to employ Zhang et al. Bioresour. Bioprocess. (2019) 6:9 the optimum conditions (pH 7.5, 25 °C, 100 g L −1 l-Met, and 20 g L −1 wet biomass), the titer of KMTB improved to 98.5 g L −1 with a conversion rate of 99.2% (Fig. 2e) . The whole-cell catalysis reaction was then performed at 1 L. Under the optimized conditions, a total of 100 g L −1
of l-Met was converted after 14 h of incubation at 25 °C with an aeration rate of 2 vvm, reaching 99.0 g L −1 KMTB (Fig. 2f) . The obtained product KMTB was finally identified by mass spectrometry (Additional file 1: Figure S3a ) and quantified by HPLC (Additional file 1: Figure S4 ).
Production of (R)-HMTBA from KMTB
The substrate specificity of dehydrogenases provides a theoretical basis for choosing dehydrogenase candidates. For one, KMTB and phenylpyruvate (PPA) have a similar structure. However, the KMTB substrate size is smaller than that of the PPA. Therefore, we assumed that dehydrogenases for PPA would also recognize KMTB as a substrate. To construct EM1, highly selective dehydrogenases (ee > 99%) with an R-stereopreference from Lactobacillus sp. CGMCC9967 (Xu et al. 2016) , Lactobacillus paracasei DSM 20008 (Gourinchas et al. 2015) , and Pediococcus acidilactici (Mu et al. 2012 ) were selected and expressed in E. coli BL21 (DE3), respectively. We then tested their activities toward KMTB, showing that the R-specific lactate dehydrogenase (d-LDH) from P. acidilactici was the most suitable for the conversion of KMTB to (R)-HMTBA with a specific activity of 0.68 U mg −1 lyophilized cells (Additional file 1: Table S3 ).
Next, we designed an R-selective whole-cell catalyst (Additional file 1: Figure S1b ) to construct EM1 using a one-plasmid strategy. The genes that encode the R-specific LDH from P. acidilactici and the codon-optimized formate dehydrogenase (FDH) from Candida boidinii were ligated together into plasmid pET28a(+) to obtain pET-28a(+)-FDH-SD-d-LDH. E. coli BL21 was used as the host organism for expression. The transferred strain produced 68.4 g L −1 (R)-HMTBA from 90 g L −1 KMTB in 15 h (Fig. 3a ). The reaction system was then optimized in terms of pH, temperature, and the NAD + addition amount ( Fig. 3b-d) . Under the optimum conditions (pH 7.0, 30 °C, 0.4 mM NAD + , 20 g L −1 wet biomass), the titer of (R)-HMTBA improved to 88.5 g L −1 with a conversion rate of 97.0% within 15 h (Fig. 3e) . S-specific dehydrogenases for converting KMTB into (S)-HMTBA and FDH for NADH recycling.
The enzymes used in each module were selected on the basis of literature reports on the abilities of specific enzymes and organisms to function in the presence of the required intermediates. To facilitate suitable adjustment of the ratio of different enzymes, each module was cloned into one E. coli strain harboring one plasmid [pET28a(+)], respectively (Additional file 1: Figure S1 ). Protein expression was induced with isopropyl-β-d-lthiogalactopyranoside (IPTG), and an SDS-PAGE analysis confirmed the soluble expression of all the enzymes used (Additional file 1: Figure S2 ).
Production of KMTB from l-Met
We initially validated the system design by focusing on building a capable BM (Fig. 1a) , which required an efficient enzyme (l-AAD or l-AAO). To this end, the genes encoding two l-AADs from Proteus vulgaris (Pvl-AAD) codonoptimized based on the E. coli codon preference and P. mirabilis (Pmirl-AAD) along with seven functionally known l-AAOs were selected from the NCBI database via data mining (Hossain et al. 2014) , and expressed in E. coli BL21 (DE3). Next, the activities toward l-Met were tested (Additional file 1: Table S2 ). No activities were detected in any of the strains overexpressing the l-AAOs. In contrast, Pvl-AAD and Pmirl-AAD showed high activities toward l-Met with a specific activity 0.28 U mg −1 and 0.15 U mg −1 lyophilized cells, respectively. This improved activity is attributed to the fact that l-AADs are membrane bound and transfer electrons of the reduced cofactor to a cytochrome linked to the respiratory chain without hydrogen peroxide production. Therefore, the Pvl-AAD whole-cell catalyst was deemed to be the most suitable for constructing the BM owing to its highest activity.
Tolerance of the high substrate concentration is the key factor to consider when applying enzyme technology on an industrial scale (Groger et al. 2006) . Therefore, the transformation was conducted in the presence of 20 g L −1
wet biomass with 100 g L −1 l-Met in shake flasks (Fig. 2a) . The Pvl-AAD whole-cell catalyst produced 77.4 g L −1
KMTB in 24 h. Furthermore, the effects of different components and conditions such as pH, temperature, and substrate concentration were optimized (Fig. 2b-d ). Under (See figure on previous page.) Zhang et al. Bioresour. Bioprocess. (2019) Moreover, the synthetic application of EM1 was demonstrated by biotransformations to produce (R)-HMTBA using KMTB at 1 L. Under the optimum conditions, 98.2% KMTB was converted to (R)-HMTBA within 8 h (Fig. 3f ) . The obtained product (R)-HMTBA was finally identified by mass spectrometry (Additional file 1: Figure  S3b ) and quantified by HPLC (Additional file 1: Figure  S5b ). The enantiomeric excess of (R)-HMTBA (ee > 99%) was determined by HPLC using a chiral column (Additional file 1: Figure S6b ).
Production of (S)-HMTBA from KMTB
Similarly, to construct EM2, highly selective dehydrogenases (ee > 99%) with an S-stereopreference from Lactobacillus confuses DSM20196 (Busto et al. 2014) and Bacillus coagulans (Zheng et al. 2015) were selected and expressed in E. coli BL21 (DE3). As shown in Additional file 1: Table S3 , the S-specific lactate dehydrogenase (l-LDH) from B. coagulans was found to be particularly useful owing to its high specific activity toward KMTB of 0.67 U mg −1 lyophilized cells. The analogous S-selective whole-cell catalyst was constructed in the same manner using E. coli BL21 as the host organism using the plasmid pET28a(+), which contained genes encoding the abovementioned l-LDH from B. coagulans and the codonoptimized FDH gene from Candida boidinii to obtain pET28a(+)-FDH-SD-l-LDH (Additional file 1: Figure  S1c ).
This strain produced 67.3 g L −1 (S)-HMTBA from 90 g L −1 KMTB in 15 h (Fig. 4a) . Under the optimum conditions (pH 7.0, 30 °C, 0.4 mM NAD + , 20 g L −1 wet biomass; Fig. 4b-e) , the titer of (S)-HMTBA improved to 87.4 g L −1 with a conversion rate of 96.5% within 15 h. In addition, the synthetic application of EM2 was demonstrated by biotransformations to produce (S)-HMTBA by KMTB at 1 L. Under the optimum conditions, 96.7% KMTB was converted to (S)-HMTBA within 8 h (Fig. 4f ) . The obtained product (S)-HMTBA was finally identified by mass spectrometry (Additional file 1: Figure S3c ) and quantified by HPLC (Additional file 1: Figure S5c ). The enantiomeric excess of (S)-HMTBA (ee > 99%) was determined by HPLC with a chiral column (Additional file 1: Figure S6c ).
One-pot production of (R/S)-HMTBA from l-Met
The BM and EMs were then combined for the production of (R)-HMTBA or (S)-HMTBA from l-Met in one pot. The cascade for the production of (R)-HMTBA or (S)-HMTBA was challenging in simultaneous mode owing to the significant differences in the optimal temperatures between the modules (25 °C for the BM and 30 °C for the EMs), resulting in the enzyme incompatibility under the reaction conditions. Therefore, we designed a "two stages in one pot" strategy for the multi-enzyme cascade reaction to produce (R)-HMTBA or (S)-HMTBA using lMet, respectively (Fig. 5a ). In the first stage, the BM was performed to favor Pvl-AAD catalysis at 25 °C. In the second stage, EM1 or EM2 was initiated by adding the Ror S-selective whole-cell catalyst, formate, and NAD + at 30 °C.
Next, we tested the one-pot production of (R)-HMTBA and (S)-HMTBA from l-Met at 1 L, respectively. In the first stage, the BM was performed at a substrate concentration of 100 g L −1 l-Met at 25 °C, and a conversion rate of 99.6% was obtained after a reaction time of 14 h with 20 g L −1 Pvl-AAD wet biomass (Fig. 5b, c) . In the second stage, the reaction temperature was elevated to 30 °C, the optimal temperature for EM1 and EM2. After a further 9-h incubation with 20 g L −1 wet biomass for R-or S-selective whole-cell catalyst, 96.9% and 95.8% lMet were converted to (R)-HMTBA and (S)-HMTBA, respectively. Finally, (R)-HMTBA and (S)-HMTBA were isolated at a 79% and 77% yield, respectively, after a simple extraction step.
Discussion
A two-stage strategy has been widely applied in other multi-enzyme cascades. For example, owing to optimal pH differences between P450 monooxygenase and amine dehydrogenase, Yu et al. (2018) applied this strategy to elevate the cyclohexylamine yield up to 92.5%. In addition, Zhang et al. (2017) designed a microenvironment using poly(methacrylic acid) to separate Cytochrome C (CytC) which has an acidic optimal pH, from alkaline conditions. When operating alongside d-AAO, which is active under alkaline conditions, the cascade throughput showed tenfold enhancement compared to that conducted with unmodified CytC. Liu et al. (2018) also screened a new d-carbamoylase from Arthrobacter crystallopoietes with an optimum pH of 8.5, which was much more compatible for hydantoinase processes than other reported d-N-carbamoylases. As a result, 80 mM l-indolylmethylhydantoin could be fully converted to d-Trp within 12 h at a 0.5-L scale. Overall, there are three strategies to solve the problem of enzyme incompatibility of the environment: (i) a two-stage strategy from a time perspective, (ii) designing a microenvironment for separating enzymes from the reaction medium from a space perspective, and (iii) screening enzymes with new properties.
In the cascade route designed in the present study, the EMs were used to control the product configurations, respectively. EM1 facilitates the formation of (R)-HMTBA via the high stereoselectivity of R-specific LDH, whereas EM2 facilitates the formation of (S)-HMTBA via the high stereoselectivity of S-specific LDH. With Zhang et al. Bioresour. Bioprocess. (2019) this level of control, optically pure (R)-HMTBA and (S)-HMTBA were finally obtained, respectively. From an organic synthesis perspective, to achieve control of product configurations, use of the whole cascade is advantageous over the majority of other enzymatic (e.g., asymmetric reduction, HMTBN as a substrate, kinetic resolution) and chemical processes. Asymmetric reduction uses keto acids (Gao et al. 2017; Parmeggiani et al. 2016 ) as substrates; however, KMTB is not an available substrate and is much more expensive than the corresponding l-Met. Nitrilase-or nitrile hydratase-mediated enzymatic processes use HMTBN as a substrate and show low stereoselectivity (Rey et al. 2004) ; the yield of a kinetic resolution by enzymatic catalysts is limited to only 50% because only half the configuration is converted (Xue et al. 2013 ). In the related chemical diazotization process, the product configurations are the same as natural l-amino acids and cannot easily be inversed (Busto et al. 2014) .
In summary, we have developed an elegant biocatalytic process that nicely exploits the power of cascades, with several advantages. First, the process is clean because of the use of molecular oxygen as an oxidant and formate as a reducing agent, while only water and CO 2 are generated as by-products. Second, this biocatalytic cascade shows industrial application potential with large-scale (1 L) preparation confirmed. Furthermore, this elegant route will enable the preparation of other valuable enantiopure 
